Uncategorized

September 14, 2018

What The After Party Gets Right About Epilepsy

“When an aspiring rapper goes viral for all the wrong reasons, he thinks his career is over. But when his best friend gets them into a […]
August 13, 2018

A FACES-Inspired Clinical Trial – Engage Therapeutics CEO, Greg Mayes

Read the article by Greg Mayes, Engage Therapeutics CEO, in FACES Annual Newsletter 2018: View the full newsletter here (PDF)
June 27, 2018

Engage Therapeutics CEO, Greg Mayes, makes opening remarks to Clinical Investigators at the StATES Investigator Meeting. New Orleans, LA – June 8, 2018

Engage Therapeutics CEO, Greg Mayes, makes opening remarks to Clinical Investigators at the StATES Investigator Meeting. New Orleans, LA – June 8, 2018
May 18, 2018

STACCATO® ALPRAZOLAM

G. Mayes CEO, Engage Therapeutics, Summit, NJ, United States Staccato Alprazolam (STAP-001) is a single-use, hand-held, drug-device combination product that provides rapid systemic delivery by inhalation […]